Optical News
Get insights on optical news with press releases highlighting trends, innovations, and research advancing eye care and vision technology. Stay informed on key developments in the optical industry and explore opportunities in vision correction and eye health.
Mar 17, 2026 at 9:15 AM
Vision Loss Takes an Emotional Toll. Hadley Is Addressing It.
WINNETKA, Ill.--(BUSINESS WIRE)--Hadley's free video series on the emotional impact of vision loss draws its strongest early response, pointing to a gap in vision care....
Mar 17, 2026 at 9:00 AM
Credo Launches 800G ZeroFlap Optical Transceivers Engineered for AI Networks
SAN JOSE, Calif.--(BUSINESS WIRE)--Credo launches 800G ZeroFlap optical transceivers engineered for AI networks....
Mar 17, 2026 at 8:30 AM
Aldeyra Therapeutics Receives Complete Response Letter from the U.S. Food and Drug Administration for the Reproxalap New Drug Application for the Treatment of Signs and Symptoms of Dry Eye Disease
LEXINGTON, Mass.--(BUSINESS WIRE)--Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a biotechnology company devoted to discovering and developing innovative therapies designed to treat immune-mediated diseases, today announced receipt of a Complete Response Letter (CRL) from the U.S. Food and Drug Administration (FDA) for the New Drug Application (NDA) of reproxalap, an investigational drug candidate, for the treatment of dry eye disease. The CRL stated that there is “a lack of substantial...
Mar 16, 2026 at 4:57 PM
Alcon and LENSAR, Inc. Agree to Terminate Merger Agreement
GENEVA--(BUSINESS WIRE)--Alcon and LENSAR, Inc. Agree to Terminate Merger Agreement...
Mar 12, 2026 at 9:27 AM
Neurotech Provides Corporate Update on Commercial Progress
CUMBERLAND, R.I.--(BUSINESS WIRE)--Neurotech Pharmaceuticals, Inc. (the “Company”) today provided an update on its ongoing transition to a commercial‑stage company following the first anniversary of the FDA’s approval of ENCELTO™ (taroretcel-lwey), the Company’s encapsulated cell‑based gene therapy for adults with idiopathic Macular Telangiectasia Type 2 (MacTel). ENCELTO continues to be integrated into retina practices nationwide, supported by expanding access and established commercial manufa...
Mar 12, 2026 at 8:00 AM
Johnson & Johnson Announces FDA Approval of TECNIS PureSee Intraocular Lens, a Breakthrough Solution for U.S. Cataract Patients
JACKSONVILLE, Fla.--(BUSINESS WIRE)--Johnson & Johnson Announces FDA Approval of TECNIS PureSee Intraocular Lens, a Breakthrough Solution for U.S. Cataract Patients...
Mar 12, 2026 at 7:00 AM
Heru Showcases PretestPro™ for the Heru VR-Powered Diagnostic Headset at Vision Expo
MIAMI--(BUSINESS WIRE)--Heru, the leader in AI-powered vision diagnostics, announced it is showcasing the new PretestPro on its Heru wearable platform at Vision Expo 2026....
Mar 11, 2026 at 7:00 AM
Aurion Biotech Appoints World Renowned Cornea Surgeon Marjan Farid, M.D., to Chair Medical Advisory Board
SEATTLE & CAMBRIDGE, Mass. & TOKYO--(BUSINESS WIRE)--Aurion Biotech, Inc. (“Aurion”), a commercial-stage regenerative cell therapy company dedicated to restoring vision and working toward a future where blindness is eliminated, today announced the appointment of Dr. Marjan Farid of the Gavin Herbert Eye Institute at the University of California-Irvine (UCI) as Chair of Aurion Biotech’s medical advisory board (MAB). Dr. Farid is a distinguished cornea, cataract and refractive surgeon, a global e...
Mar 10, 2026 at 11:49 AM
Sightview Unveils Fresh Patient Engagement Tools at Vision Expo 2026
DURHAM, N,C.--(BUSINESS WIRE)--Sightview will showcase two recently updated tools for its eyecare-specific EHR/PM offering at Vision Expo 2026. See demos in booth #4021....
Mar 10, 2026 at 8:00 AM
National Vision Announces Winners of 11th Annual Scholarship Program
DULUTH, Ga.--(BUSINESS WIRE)--National Vision Announces Winners of 11th Annual Scholarship Program...
Media & Journalist Tools
From headlines to storylines—Business Wire delivers the news you need, when you need it.